A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy

NCT02767765 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: r-HuEPO

Sponsor

Hoffmann-La Roche